Search

Science & Tech

CTE blood test study finds marker linked to advanced disease

The small study examined 21 deceased former football players; researchers say the finding needs validation.

Two JAMA studies found evidence that advanced chronic traumatic encephalopathy might be detected in living people using a blood test. The latest study was published Thursday. Until now, doctors could confirm the brain disease, known as CTE, only by autopsy.

Boston University and Banner Health researchers published the Thursday study after a Washington University in St. Louis team identified the same blood marker in JAMA on Nov. 13. Scientists investigating football's link to brain damage have long described diagnosing CTE during life as the holy grail.

“This is a game changer,” said Michael Alosco, co-director of clinical research at Boston University's CTE Center.

“We are still in the discovery phase and it's a small sample size, but if future studies validate these findings, this blood test will allow us to detect CTE with a high level of accuracy and open the doors to clinical trials and treatment,” Alosco said.

Football players are not the only people affected. The disease has also been identified among athletes in other sports and military members, first responders and others who experienced repeated blows to the head. There are no tests or treatments specific to CTE approved by the U.S. Food and Drug Administration.

Blood samples and brain donations

The Boston University team studied 21 deceased former American football players who had provided blood during life and donated their brains after death to the B.U. CTE Center Brain Bank.

Of those players, 12 had played professionally and seven had reached college, while high school was the highest level for two, according to ESPN. Autopsies found CTE in 18 of the 21 players, while three did not have it.

Advanced-stage CTE appeared in most of the former professionals, along with four college players and one high school player.

Tau normally helps support neurons, but in Alzheimer's disease the protein becomes abnormal and forms tangles inside nerve cells. The Boston University study found higher blood concentrations of tau among players with advanced CTE than among those with low-stage disease or no CTE.

The highest levels belonged to five players who had both CTE and Alzheimer's disease. The study found promise for identifying advanced CTE during life, but not its early stages. Early CTE often causes no symptoms. At an advanced stage, people can experience confusion, memory loss, irritability, depression and severe mood swings.

A chance finding

The Washington University team encountered the CTE signal by chance while examining the tau fragment eMTBR-tau243 in autopsy samples for Alzheimer's research. One patient had elevated levels of the marker but had advanced CTE, rather than Alzheimer's. The study drew on 11 CTE cases.

Chihiro Sato, a study co-author and assistant neurology professor, told The Associated Press that people with advanced CTE had higher levels than healthy people. She said the marker could not reliably identify early-stage CTE and considerably more research was needed.

Dr. Rudolph Castellani, a Northwestern University neuropathologist who did not take part, said the result was interesting but very preliminary and called for far larger studies.

It is not known whether the marker can distinguish CTE from other tau diseases in larger groups that include women and non-athletes.

Players' views on testing

Last summer, ESPN asked more than 30 current and former NFL players about CTE, including whether they would take a test were one available.

Washington Commanders quarterback Marcus Mariota said in 2026 he would take one. “I think because, at the end of the day, it gives insight to the rest of the NFL, to college kids, to high school kids of what we're getting ourselves into,” he told ESPN.

Minnesota Vikings safety Joshua Metellus said in 2026 he probably would not. “I probably wouldn't want [the test] while I'm in the league, because I think it'll change the way I play,” he told ESPN.

“I'm cautiously optimistic that we can really understand this finding and move it forward in the next five years or so,” Alosco told ESPN.

Sources

Latest from Inquisitr

Front page